The Wiskott-Aldrich syndrome protein: forging the link between actin and cell activation

被引:66
作者
Badour, K
Zhang, JY
Siminovitch, KA
机构
[1] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med Immunol & Med Genet & Microbiol, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Mt Sinai Hosp, Toronto Gen Hosp Res Inst, Dept Med Immunol & Med Genet & Microbiol, Toronto, ON M5G 1X5, Canada
关键词
D O I
10.1034/j.1600-065X.2003.00031.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Wiskott-Aldrich syndrome protein (WASp) has emerged as a central player in the regulation of actin remodeling in T cells. The unique domain structure of WASp and other WASp family members enables these proteins to associate with a myriad of signaling effectors and to thereby regulate the coupling of T cell antigen receptor (TCR) engagement to both cytoskeletal rearrangement and transcriptional activation. This review focuses on these biochemical properties of WASp and also on the mechanisms whereby WASp interactions with its cognate ligands influence T cell activation. Because of its capacity to shift intracellular location and thereby dictate both the timing and the spatial distribution of actin polymerization following cell stimulation, WASp is well positioned to play major regulatory roles in directing a wide range of cellular processes and signaling pathways. Further dissection of the functional and biochemical properties of WASp therefore represents a promising avenue towards defining the molecular mechanisms that convey TCR stimulatory signals to the actin cytoskeleton and integrate cytoskeletal and other signaling systems so as to evoke a biological response.
引用
收藏
页码:98 / 112
页数:15
相关论文
共 150 条
  • [1] Structure of Cdc42 in complex with the GTPase-binding domain of the 'Wiskott-Aldrich syndrome' protein
    Abdul-Manan, N
    Aghazadeh, B
    Liu, GA
    Majumdar, A
    Ouerfelli, O
    Siminovitch, KA
    Rosen, MK
    [J]. NATURE, 1999, 399 (6734) : 379 - 383
  • [2] Adams A, 2000, J BIOL CHEM, V275, P27414
  • [3] Allavena P, 2001, EUR J IMMUNOL, V31, P3413, DOI 10.1002/1521-4141(200112)31:12<3413::AID-IMMU3413>3.0.CO
  • [4] 2-P
  • [5] The Wiskott-Aldrich syndrome protein-interacting protein (WIP) binds to the adaptor protein Nck
    Anton, IM
    Lu, WG
    Mayer, BJ
    Ramesh, N
    Geha, RS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) : 20992 - 20995
  • [6] Two GTPases, cdc42 and rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome
    Aspenstrom, P
    Lindberg, U
    Hall, A
    [J]. CURRENT BIOLOGY, 1996, 6 (01) : 70 - 75
  • [7] Impaired interienkin-2 production in T-cells from a patient with Wiskott-Aldrich syndrome: basis of clinical effect of interleukin-2 replacement therapy
    Azuma, H
    Oshima, M
    Ito, K
    Okuno, A
    Kawabata, I
    Banba, K
    Murahashi, H
    Sekine, T
    Kato, Y
    Ikebuchi, K
    Ikeda, H
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (08) : 633 - 634
  • [8] Involvement of Wiskott-Aldrich syndrome protein in B-Cell cytoplasmic tyrosine kinase pathway
    Baba, Y
    Nonoyama, S
    Matsushita, M
    Yamadori, T
    Hashimoto, S
    Imai, K
    Arai, S
    Kunikata, T
    Kurimoto, M
    Kurosaki, T
    Ochs, HD
    Yata, J
    Kishimoto, T
    Tsukada, S
    [J]. BLOOD, 1999, 93 (06) : 2003 - 2012
  • [9] The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation
    Bachmann, C
    Fischer, L
    Walter, U
    Reinhard, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) : 23549 - 23557
  • [10] Badolato R, 1998, J IMMUNOL, V161, P1026